Moreover, in an amyloid-beta precursor protein/presenilin 1 (APP/PS1) transgenic mouse model for AD, AQP4-knockout mice show a reduced Aβ clearance rate of 25–50% compared to transgenic mice without AQP4-knockout [16]. Here, APP is linked to Alzheimer disease.